
Sign up to save your podcasts
Or


Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk to discuss his career from NIH, to CEO of Avidea, to their merger with Vaccitech.
By BioHealth Innovation, Inc. (BHI)4.7
1111 ratings
Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk to discuss his career from NIH, to CEO of Avidea, to their merger with Vaccitech.

10,182 Listeners